The p53 tumour suppressor inhibits glucocorticoid‐induced proliferation of erythroid progenitors

Hypoxia encountered at high altitude, blood loss and erythroleukemia instigate stress erythropoiesis, which involves glucocorticoid‐induced proliferation of erythroid progenitors (ebls). The tumour suppressor p53 stimulates hematopoietic cell maturation and antagonizes glucocorticoid receptor (GR) activity in hypoxia, suggesting that it may inhibit stress erythropoiesis. We report that mouse fetal liver ebls that lack p53 proliferate better than wild‐type cells in the presence of the GR agonist dexamethasone. An important mediator of GR‐induced ebl self‐renewal, the c‐myb gene, is induced to higher levels in p53−/− ebls by dexamethasone. The stress response to anemia is faster in the spleens of p53−/− mice, as shown by the higher levels of colony forming units erythroids and the increase in the CD34/c‐kit double positive population. Our results show that p53 antagonizes GR‐mediated ebl expansion and demonstrate for the first time that p53–GR cross‐talk is important in a physiological process in vivo: stress erythropoiesis.

[1]  K. Vousden,et al.  Activation and activities of the p53 tumour suppressor protein , 2001, British Journal of Cancer.

[2]  B. Wasylyk,et al.  Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. , 2001, Genes & development.

[3]  B. Kennedy,et al.  NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. , 2000, Genes & development.

[4]  D. Notterman,et al.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. , 2000, Genes & development.

[5]  C. Kellendonk,et al.  The glucocorticoid receptor is required for stress erythropoiesis. , 1999, Genes & development.

[6]  H. Beug,et al.  The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. , 1999, Blood.

[7]  C. Kellendonk,et al.  Genetic dissection of glucocorticoid receptor function in mice. , 1998, Current opinion in genetics & development.

[8]  K. Kaestner,et al.  DNA Binding of the Glucocorticoid Receptor Is Not Essential for Survival , 1998, Cell.

[9]  K. Weston Myb proteins in life, death and differentiation. , 1998, Current opinion in genetics & development.

[10]  V. Rotter,et al.  Involvement of p53 in cell differentiation and development. , 1997, Biochimica et biophysica acta.

[11]  H. Beug,et al.  Distinct roles of the receptor tyrosine kinases c-ErbB and c-Kit in regulating the balance between erythroid cell proliferation and differentiation. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[12]  H. Beug,et al.  The glucocorticoid receptor is a key regulator of the decision between self‐renewal and differentiation in erythroid progenitors , 1997, The EMBO journal.

[13]  Y Fujiwara,et al.  Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  V. Broudy,et al.  Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen. , 1996, Blood.

[15]  K. Muta,et al.  Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. , 1995, Blood.

[16]  V. Rotter,et al.  Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. , 1994, Blood.

[17]  M. Evans,et al.  The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.

[18]  T. Chan,et al.  Childhood acute lymphoblastic leukaemia and aplastic anaemia. , 1994, Leukemia & lymphoma.

[19]  M. Arsura,et al.  The myb oncogene family of transcription factors: potent regulators of hematopoietic cell proliferation and differentiation. , 1994, Seminars in cancer biology.

[20]  J. Lotem,et al.  Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. , 1993, Blood.

[21]  D. Golde The stem cell. , 1991, Scientific American.

[22]  C. Wolkow,et al.  Levels of p53 protein increase with maturation in human hematopoietic cells. , 1991, Cancer research.

[23]  K. Udupa,et al.  In vitro culture of proerythroblasts: characterization of proliferative response to erythropoietin and steroids , 1986, British journal of haematology.

[24]  J. Axelrod,et al.  Stress hormones: their interaction and regulation. , 1984, Science.

[25]  H. Zentgraf,et al.  Hormone-dependent terminal differentiation in vitro of chicken erythroleukemia cells transformed by ts mutants of avian erythroblastosis virus , 1982, Cell.

[26]  E. C. Lynch,et al.  Prednisone-responsive congenital erythroid hypoplasia. , 1977, JAMA.

[27]  M. Hollstein,et al.  p53 and human cancer: the first ten thousand mutations. , 2000, Advances in cancer research.

[28]  H. Beug,et al.  A Novel Way to Induce Erythroid Progenitor Self Renewal: Cooperation of c-Kit with the Erythropoietin Receptor , 1999, Biological chemistry.

[29]  S. Orkin,et al.  Development of hematopoietic cells lacking transcription factor GATA-1. , 1995, Development.

[30]  N. Bersch,et al.  Potentiation of erythropoiesis in vitro by dexamethasone. , 1976, The Journal of clinical investigation.